UK markets closed
  • FTSE 100

    7,129.71
    +53.54 (+0.76%)
     
  • FTSE 250

    22,775.28
    +283.92 (+1.26%)
     
  • AIM

    1,262.60
    +9.91 (+0.79%)
     
  • GBP/EUR

    1.1495
    -0.0015 (-0.13%)
     
  • GBP/USD

    1.3990
    +0.0098 (+0.70%)
     
  • BTC-GBP

    42,033.25
    +713.80 (+1.73%)
     
  • CMC Crypto 200

    1,480.07
    +44.28 (+3.08%)
     
  • S&P 500

    4,232.60
    +30.98 (+0.74%)
     
  • DOW

    34,777.76
    +229.23 (+0.66%)
     
  • CRUDE OIL

    64.82
    +0.11 (+0.17%)
     
  • GOLD FUTURES

    1,832.00
    +16.30 (+0.90%)
     
  • NIKKEI 225

    29,357.82
    +26.45 (+0.09%)
     
  • HANG SENG

    28,610.65
    -26.81 (-0.09%)
     
  • DAX

    15,399.65
    +202.91 (+1.34%)
     
  • CAC 40

    6,385.51
    +28.42 (+0.45%)
     

Insights on the Periodontal Therapeutics Global Market to 2027 - Featuring 3M, Align Technology and Bausch Health Companies Among Others - ResearchAndMarkets.com

·2-min read

The "Periodontal Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Periodontal Therapeutics estimated at US$336.9 Million in the year 2020, is projected to reach a revised size of US$605.5 Million by 2027, growing at a CAGR of 8.7% over the period 2020-2027.

Systemic Antibiotics, one of the segments analyzed in the report, is projected to record 8.7% CAGR and reach US$471.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Local Antibiotics segment is readjusted to a revised 9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $91.1 Million, While China is Forecast to Grow at 11.8% CAGR

The Periodontal Therapeutics market in the U.S. is estimated at US$91.1 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$125.8 Million by the year 2027 trailing a CAGR of 11.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Select Competitors (Total 38 Featured):

  • 3M ESPE

  • Align Technology, Inc.

  • Bausch Health Companies Inc.

  • DenMat Holdings LLC

  • DENTSPLY International, Inc.

  • Eli Lilly and Company

  • Fibrocell Science, Inc.

  • Glidewell Laboratories

  • Kaken Pharmaceutical Co., Ltd.

  • Mallinckrodt Pharmaceuticals

  • Nobel Biocare Holding AG

  • OraPharma

  • Purdue Pharma LP

  • Teva Pharmaceutical Industries Ltd.

  • TOLMAR Pharmaceuticals, Inc.

  • Ultradent Products, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES

  • CANADA

  • JAPAN

  • CHINA

  • EUROPE

  • FRANCE

  • GERMANY

  • ITALY

  • UNITED KINGDOM

  • SPAIN

  • RUSSIA

  • REST OF EUROPE

  • ASIA-PACIFIC

  • AUSTRALIA

  • INDIA

  • SOUTH KOREA

  • REST OF ASIA-PACIFIC

  • LATIN AMERICA

  • ARGENTINA

  • BRAZIL

  • MEXICO

  • REST OF LATIN AMERICA

  • MIDDLE EAST

  • IRAN

  • ISRAEL

  • SAUDI ARABIA

  • UNITED ARAB EMIRATES

  • REST OF MIDDLE EAST

  • AFRICA

IV. COMPETITION

  • Total Companies Profiled: 38

For more information about this report visit https://www.researchandmarkets.com/r/lmnzy0

View source version on businesswire.com: https://www.businesswire.com/news/home/20210419005612/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900